Biology:List of 5α-reductase inhibitors

From HandWiki
Short description: none

This is a list of 5α-reductase inhibitors (5α-RIs), drugs which inhibit one or more isoforms of the enzyme 5α-reductase. This enzyme is responsible for the conversion of the androgen hormone testosterone into the more potent dihydrotestosterone (DHT) and is essential for the production of neurosteroids like allopregnanolone, tetrahydrodeoxycorticosterone (THDOC), and 3α-androstanediol from progesterone, deoxycorticosterone, and DHT, respectively. 5α-Reductase inhibitors have medical applications in the treatment of benign prostatic hyperplasia, androgenic alopecia (pattern hair loss), and hirsutism (excessive hair growth).

Pharmaceutical drugs

5α-RIs that are used in medicine include the following:

Experimental drugs

5α-RIs that were under development for potential clinical use but were never marketed or are used in research include the following:

  • 4-MA – inhibits types 1 and 2 (IC50 = 8.5 nM), but also 3β-HSD inhibitor, investigated extensively but found to be hepatotoxic[1]
  • 17β-Carboxy-4-androsten-3-one[2][3]
  • AS-97004
  • Azelaic Acid[4]
  • Bexlosteride (LY-300502) – inhibits type 1
  • CGP-53153
  • Efomycin G (SNA 4606-2)
  • EM-402
  • FCE-28260 – inhibits types 1 and 2
  • FK-143
  • FR-146687
  • G-20000
  • Izonsteride (LY-320236) – inhibits types 1 and 2
  • L-10
  • L-39
  • L-697818
  • L-751788 (16-((4-chlorophenyl)oxy)-4,7-dimethyl-4-azaandronstan-3-one)
  • Lapisteride (CS-891) – inhibits types 1 and 2
  • LY-191704
  • LY-266111
  • MK-386 (L-733692) – inhibits type 1
  • MK-434 – inhibits type 2[5]
  • MK-963 (L-654066) – inhibits type 2
  • ONO-3805 (ONO-RI-3805)
  • PHL-00801 (Prostatonin; PY 102/UR 102; Pygeum africanum/Urtica dioica extract)
  • PNU-157706 – inhibits types 1 and 2[6]
  • Steroidal oximes[7][3]
  • Turosteride (FCE-26073) – inhibits type 2 and to a 15-fold lesser extent type 1
  • Z-350 – also an α1-adrenergic receptor antagonist[8]

Herbs and other inhibitors

Many plants, as well as their associated phytochemical constituents, have inhibitory effects on 5α-reductase.[9] In addition, many of these compounds are also phytoestrogens. Examples include the following:

These supplements have limited testing in human clinical trials, and their potential for the treatment of BPH, androgenic alopecia, and related conditions is unknown.

References

  1. "5 alpha-reductase inhibitors, chemical and clinical models". Steroids 63 (5–6): 355–61. 1998. doi:10.1016/S0039-128X(98)00020-8. PMID 9618802. 
  2. "Inhibition of dihydrotestosterone formation: an effective means of blocking androgen action in hamster sebaceous gland". The Journal of Investigative Dermatology 62 (3): 224–7. March 1974. doi:10.1111/1523-1747.ep12676791. PMID 4361987. 
  3. 3.0 3.1 "Steroid 5α-Reductase Inhibitors". Mini Reviews in Medicinal Chemistry 3 (3): 225–37. May 2003. doi:10.2174/1389557033488196. PMID 12570838. 
  4. 4.0 4.1 4.2 "Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid". The British Journal of Dermatology 119 (5): 627–32. November 1988. doi:10.1111/j.1365-2133.1988.tb03474.x. PMID 3207614. 
  5. "Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression". The Prostate 26 (2): 55–71. February 1995. doi:10.1002/pros.2990260202. PMID 7531846. 
  6. "PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor". The Journal of Steroid Biochemistry and Molecular Biology 64 (3–4): 179–86. February 1998. doi:10.1016/S0960-0760(97)00158-1. PMID 9605412. 
  7. "Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2". Journal of Medicinal Chemistry 43 (22): 4266–77. November 2000. doi:10.1021/jm001008m. PMID 11063622. 
  8. "Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo". The Journal of Pharmacology and Experimental Therapeutics 290 (3): 1013–8. September 1999. PMID 10454472. 
  9. "Evaluation of 5α-reductase inhibitory activity of certain herbs useful as antiandrogens". Andrologia 46 (6): 592–601. August 2014. doi:10.1111/and.12115. PMID 23710567. 
  10. https://library.uniteddiversity.coop/Permaculture/Mycelium_Running.pdf p.217
  11. Plants for a Future: Angelica koreana
  12. "Inhibitors of 5alpha -reductase type I in LNCaP cells from the roots of Angelica koreana". Planta Medica 68 (2): 162–3. February 2002. doi:10.1055/s-2002-20258. PMID 11859469. 
  13. Anderson, Mark L. (2005). "A preliminary investigation of the enzymatic inhibition of 5alpha-reduction and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and Saw Palmetto lipid extract in vitro". Journal of Herbal Pharmacotherapy 5 (1): 17–26. doi:10.1080/J157v05n01_03. ISSN 1522-8940. PMID 16093232. https://pubmed.ncbi.nlm.nih.gov/16093232/. 
  14. "Testosterone 5alpha-reductase inhibitory active constituents of Piper nigrum leaf". Biological & Pharmaceutical Bulletin 30 (12): 2402–5. December 2007. doi:10.1248/bpb.30.2402. PMID 18057734. 
  15. "Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate". Proceedings of the Western Pharmacology Society 46: 153–5. 2003. PMID 14699915. 
  16. "Polygonum multiflorum Thunb.: A Review on Chemical Analysis, Processing Mechanism, Quality Evaluation, and Hepatotoxicity". Frontiers in Pharmacology 9 (1): 364. April 2018. doi:10.3389/fphar.2018.00364. PMID 29713283. 
  17. Sk, Kim; H, Seok; Hj, Park; Hs, Jeon; Sw, Kang; Bc, Lee; J, Yi; Sy, Song et al. (2015-10-22). "Inhibitory Effect of Curcumin on Testosterone Induced Benign Prostatic Hyperplasia Rat Model" (in en). BMC Complementary and Alternative Medicine 15: 380. doi:10.1186/s12906-015-0825-y. PMID 26490686. 
  18. Ide, Hisamitsu; Lu, Yan; Noguchi, Takahiro; Muto, Satoru; Okada, Hiroshi; Kawato, Suguru; Horie, Shigeo (April 2018). "Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer". Cancer Science 109 (4): 1230–1238. doi:10.1111/cas.13517. ISSN 1347-9032. PMID 29369461. 
  19. Srivilai, Jukkarin; Rabgay, Karma; Khorana, Nantaka; Waranuch, Neti; Nuengchamnong, Nitra; Wisuitiprot, Wudtichai; Chuprajob, Thipphawan; Changtam, Chatchawan et al. (2017-07-01). "Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors" (in en). Medicinal Chemistry Research 26 (7): 1550–1556. doi:10.1007/s00044-017-1869-y. ISSN 1554-8120. 
  20. "Effect of Cuscuta reflexa Roxb on androgen-induced alopecia". Journal of Cosmetic Dermatology 7 (3): 199–204. September 2008. doi:10.1111/j.1473-2165.2008.00389.x. PMID 18789055. 
  21. "The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse". Journal of Dermatological Science 31 (2): 91–8. April 2003. doi:10.1016/s0923-1811(02)00146-9. PMID 12670719. 
  22. Flora of China: Euphorbia jolkinii
  23. "Isolation of 5α-reductase inhibitors from Euphorbia jolkinii". Korean Journal of Pharmacognosy 36 (1): 9–16. 2005. 
  24. "Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids". The Biochemical Journal 285 ( Pt 2) (2): 557–62. July 1992. doi:10.1042/bj2850557. PMID 1637346. 
  25. "Combination of lauric acid and myristic acid prevents benign prostatic hyperplasia symptoms in animal model". African Journal of Pharmacy and Pharmacology 10 (8): 101–106. February 2016. doi:10.1016/j.ejphar.2009.09.037. PMID 19786012. 
  26. "Anti-androgenic activity of fatty acids". Chemistry & Biodiversity 6 (4): 503–12. April 2009. doi:10.1002/cbdv.200800125. PMID 19353546. 
  27. "Cyclooxygenase-2 inhibitory 1,4-naphthoquinones from Impatiens balsamina L.". Biological & Pharmaceutical Bulletin 25 (5): 658–60. 2002. doi:10.1248/bpb.25.658. PMID 12033510. 
  28. "Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid". Archives of Dermatological Research 293 (4): 200–5. April 2001. doi:10.1007/s004030000203. PMID 11380153. 
  29. Zhou, J. R.; Yu, L.; Zhong, Y.; Blackburn, G. L. (2003). "Soy Phytochemicals and Tea Bioactive Components Synergistically Inhibit Androgen-Sensitive Human Prostate Tumors in Mice". The Journal of Nutrition 133 (2): 516–521. doi:10.1093/jn/133.2.516. PMID 12566493. "Green tea tended to increase serum testosterone and DHT levels by 73.8% (P = 0.14) and 194% (P = 0.076), respectively". 
  30. Zhou, Jin-Rong; Yu, Lunyin; Zhong, Ying; Blackburn, George L. (February 2003). "Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice". The Journal of Nutrition 133 (2): 516–521. doi:10.1093/jn/133.2.516. ISSN 0022-3166. PMID 12566493. 
  31. Lee, Hung-Hsiao; Ho, Chi-Tang; Lin, Jen-Kun (July 2004). "Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells". Carcinogenesis 25 (7): 1109–1118. doi:10.1093/carcin/bgh106. ISSN 0143-3334. PMID 14963012. 
  32. "Torilin from Torilis japonica, as a new inhibitor of testosterone 5 alpha-reductase". Planta Medica 69 (5): 459–61. May 2003. doi:10.1055/s-2003-39717. PMID 12802730. 
  33. "The hair growth promoting effect of Sophora flavescens extract and its molecular regulation". Journal of Dermatological Science 30 (1): 43–9. October 2002. doi:10.1016/s0923-1811(02)00060-9. PMID 12354419. 
  34. "Anti-androgenic activities of Ganoderma lucidum". Journal of Ethnopharmacology 102 (1): 107–12. October 2005. doi:10.1016/j.jep.2005.05.041. PMID 16029938. 
  35. "5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum". Biological & Pharmaceutical Bulletin 29 (2): 392–5. February 2006. doi:10.1248/bpb.29.392. PMID 16462054. 
  36. "Anti-androgen effects of extracts and compounds from Ganoderma lucidum". Chemistry & Biodiversity 6 (2): 231–43. February 2009. doi:10.1002/cbdv.200800019. PMID 19235153. 
  37. "Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms". Asian Journal of Andrology 10 (5): 777–85. September 2008. doi:10.1111/j.1745-7262.2008.00361.x. PMID 18097505. 
  38. "Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor". Bioorganic & Medicinal Chemistry Letters 19 (8): 2154–7. April 2009. doi:10.1016/j.bmcl.2009.02.119. PMID 19289282. 
  39. "The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum". Bioorganic & Medicinal Chemistry 15 (14): 4966–72. July 2007. doi:10.1016/j.bmc.2007.04.036. PMID 17499997. 
  40. "Effects of various pesticides on human 5alpha-reductase activity in prostate and LNCaP cells". Toxicology in Vitro 21 (3): 502–8. April 2007. doi:10.1016/j.tiv.2006.10.016. PMID 17218080. 
  41. "5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment". Journal of Ethnopharmacology 139 (3): 765–71. February 2012. doi:10.1016/j.jep.2011.12.010. PMID 22178180. 
  42. "Abietic acid from Resina Pini of Pinus species as a testosterone 5α-reductase inhibitor". Journal of Health Science 56 (4): 451–455. 2010. doi:10.1248/jhs.56.451. 
  43. "5 alpha-reductase and aromatase inhibitory constituents from Brassica rapa L. pollen". Chemical & Pharmaceutical Bulletin 57 (4): 401–4. April 2009. doi:10.1248/cpb.57.401. PMID 19336936. 
  44. "Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols". Biochemical Pharmacology 63 (6): 1165–76. March 2002. doi:10.1016/s0006-2952(02)00848-1. PMID 11931850. 
  45. "A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS". Neurourology and Urodynamics 26 (4): 458–463. 2007. doi:10.1002/nau.20136. PMID 17397059. 
  46. "Riboflavin, a testosterone 5 alpha-reductase inhibitor". The Journal of Antibiotics 43 (12): 1615–6. December 1990. doi:10.7164/antibiotics.43.1615. PMID 2276981. 
  47. "Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon". The Journal of Steroid Biochemistry and Molecular Biology 82 (2–3): 233–9. October 2002. doi:10.1016/S0960-0760(02)00187-5. PMID 12477490. 
  48. "Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II". Advances in Therapy 27 (8): 555–63. August 2010. doi:10.1007/s12325-010-0041-6. PMID 20623347. 
  49. "Pharmacologically relevant receptor binding characteristics and 5alpha-reductase inhibitory activity of free Fatty acids contained in saw palmetto extract". Biological & Pharmaceutical Bulletin 32 (4): 646–50. April 2009. doi:10.1248/bpb.32.646. PMID 19336899. 
  50. "Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors". The Journal of Steroid Biochemistry and Molecular Biology 54 (5–6): 273–9. September 1995. doi:10.1016/0960-0760(95)00134-L. PMID 7577710. 
  51. Rhodes, Linda; Primka, Raymond L.; Berman, Charles; Vergult, Gerard; Gabriel, Munir; Pierre-Malice, Marie; Gibelin, Bruno (1993). "Comparison of finasteride (proscar), a 5α reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α reductase inhibition" (in en). The Prostate 22 (1): 43–51. doi:10.1002/pros.2990220107. ISSN 1097-0045. PMID 8381228. https://onlinelibrary.wiley.com/doi/abs/10.1002/pros.2990220107. 
  52. "Anti-androgenic and hair growth promoting activities of Lygodii spora (spore of Lygodium japonicum) I. Active constituents inhibiting testosterone 5alpha-reductase". Biological & Pharmaceutical Bulletin 25 (5): 622–6. May 2002. doi:10.1248/bpb.25.622. PMID 12033503. 
  53. Yoshio, Hirano; Ryuichiro, Kondo; Kokki, Sakai (2003). "5A-Reductase inhibitory tannin-related compounds isolated from Shorea laevifolia". Journal of Wood Science 49 (4): 339–343. doi:10.1007/s10086-002-0481-y. 
  54. "Analysis of oak tannins by liquid chromatography-electrospray ionisation mass spectrometry". Journal of Chromatography A 891 (1): 75–83. September 2000. doi:10.1016/S0021-9673(00)00624-5. PMID 10999626. 

{{Navbox

| name = Androgens and antiandrogens
| title = Androgens and antiandrogens
| state = collapsed
| listclass = hlist
| groupstyle = text-align:center;
| group1 = Androgens
(incl. AAS)

| list1 =

  | group3 = Antigonadotropins
  | list3 =
  | group4 = Others
  | list4 =
}}
| liststyle = background:#DDDDFF;
| list3 =
See also
Androgen receptor modulators
Estrogens and antiestrogens
Progestogens and antiprogestogens
List of androgens/anabolic steroids

}}